Vor Biopharma (VOR) Operating Expenses (2020 - 2026)
Vor Biopharma (VOR) posted quarterly Operating Expenses of $35.2 million for Q1 2026, up 5.61% year-over-year from $33.3 million in Q1 2025, and down 2.22% quarter-over-quarter from $36.0 million in Q4 2025.
Vor Biopharma (VOR) Operating Expenses (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has reported Operating Expenses for 7 consecutive years, with $35.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Expenses rose 5.61% year-over-year to $35.2 million; the TTM figure through Mar 2026 stood at $373.5 million (up 205.78% YoY), while the FY2025 annual figure was $371.6 million, up 206.67% from the prior year.
- Operating Expenses fell to $35.2 million in Q1 2026 per VOR's latest filing, from $36.0 million in the prior quarter.
- Across five years, Operating Expenses topped out at $274.3 million in Q2 2025 and bottomed at $21.8 million in Q2 2022.
- Historically, Operating Expenses has averaged $44.0 million across 5 years, with a median of $30.4 million in 2023.
- Annual changes were most pronounced in 2024 — Operating Expenses retreated 19.26% — and 2025, when it jumped 844.67%.
- Vor Biopharma's Operating Expenses stood at $24.7 million in 2022, then grew by 13.75% to $28.1 million in 2023, then climbed by 11.33% to $31.3 million in 2024, then climbed by 14.85% to $36.0 million in 2025, then decreased by 2.22% to $35.2 million in 2026.
- Business Quant data shows VOR's Operating Expenses at $35.2 million in Q1 2026, $36.0 million in Q4 2025, and $28.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Vor Biopharma | 1.36 Bn | 1.36 Bn | - | 47.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.85 Mn |
| Mar 31, 2026 | 35.16 Mn |
| Dec 31, 2025 | 35.96 Mn |
| Sep 30, 2025 | 28.11 Mn |
| Jun 30, 2025 | 274.28 Mn |
| Mar 31, 2025 | 33.29 Mn |
| Dec 31, 2024 | 31.31 Mn |
| Sep 30, 2024 | 28.51 Mn |
| Jun 30, 2024 | 29.04 Mn |
| Mar 31, 2024 | 32.33 Mn |
| Dec 31, 2023 | 28.12 Mn |
| Sep 30, 2023 | 35.32 Mn |
| Jun 30, 2023 | 32.17 Mn |
| Mar 31, 2023 | 30.42 Mn |
| Dec 31, 2022 | 24.73 Mn |
| Sep 30, 2022 | 24.10 Mn |
| Jun 30, 2022 | 21.79 Mn |
| Mar 31, 2022 | 22.80 Mn |
| Dec 31, 2021 | 18.31 Mn |
| Sep 30, 2021 | 18.60 Mn |